| Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma (NCT00017264) | National Cancer Institute (NCI) | 2002-06-01 |
| Exercise and Shoe Orthoses in Treatment of Posterior Tibial Tendon Dysfunction (NCT00279630) | University of Southern California | 2002-06-01 |
| Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines (NCT00698100) | Memorial Sloan Kettering Cancer Center | 2002-06-01 |
| Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors (NCT00311597) | Wake Forest University Health Sciences | 2002-06-01 |
| To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules (NCT02117141) | Zogenix, Inc. | 2002-06-01 |
| Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies (NCT00037817) | National Cancer Institute (NCI) | 2002-05-17 |
| Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236) | Case Comprehensive Cancer Center | 2002-05-01 |
| Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers (NCT00356850) | Laboratoires Thea | 2002-05-01 |
| Cyberknife Precision Radiation Delivery System for Tumors of the Spine (NCT00185666) | Stanford University | 2002-05-01 |
| Endothelial Dysfunction as a Risk Factor in HIV Study (NCT00039663) | National Institutes of Health Clinical Center (CC) | 2002-05-01 |
| Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction (NCT00045318) | Jonsson Comprehensive Cancer Center | 2002-05-01 |
| Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers (NCT02251145) | Boehringer Ingelheim | 2002-05-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00032032) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions (NCT01064154) | Dr. Reddy's Laboratories Limited | 2002-05-01 |
| Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer (NCT00042835) | National Cancer Institute (NCI) | 2002-05-01 |
| Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00055614) | Beth Israel Deaconess Medical Center | 2002-05-01 |
| Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions (NCT01064180) | Dr. Reddy's Laboratories Limited | 2002-05-01 |
| Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders (NCT00153543) | Centers for Disease Control and Prevention | 2002-05-01 |
| The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin (NCT02172742) | Bial - Portela C S.A. | 2002-05-01 |
| T Cell Vaccination in Patients With Progressive Multiple Sclerosis (NCT01448252) | Hadassah Medical Organization | 2002-05-01 |
| To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions (NCT00881179) | Sandoz | 2002-05-01 |
| Progesterone Treatment of Blunt Traumatic Brain Injury (NCT00048646) | David Wright | 2002-05-01 |
| Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia (NCT00096018) | Roswell Park Cancer Institute | 2002-05-01 |
| Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00084734) | Roswell Park Cancer Institute | 2002-05-01 |
| Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer (NCT00171587) | Novartis | 2002-05-01 |
| Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers (NCT02180490) | Boehringer Ingelheim | 2002-05-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00042874) | National Cancer Institute (NCI) | 2002-05-01 |
| Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain (NCT00039572) | Beth Israel Deaconess Medical Center | 2002-05-01 |
| Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation (NCT00041548) | Mallinckrodt | 2002-05-01 |
| Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1 (NCT00040066) | National Institute on Drug Abuse (NIDA) | 2002-05-01 |
| A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery (NCT00728832) | EKR Therapeutics, Inc | 2002-05-01 |
| A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers (NCT02254538) | Boehringer Ingelheim | 2002-05-01 |
| Acceptance-Based Treatment for Generalized Anxiety Disorder (NCT00073632) | University of Massachusetts, Boston | 2002-05-01 |
| A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants (NCT00192348) | MedImmune LLC | 2002-05-01 |
| Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT (NCT00038987) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-05-01 |
| Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions (NCT00652821) | Par Pharmaceutical, Inc. | 2002-05-01 |
| Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914 (NCT00041899) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-05-01 |
| The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin (NCT02287415) | Bial - Portela C S.A. | 2002-05-01 |
| Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00042809) | National Cancer Institute (NCI) | 2002-05-01 |
| Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung (NCT00017121) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Hepatic Artery Infusion of CD34+ Cells (NCT00062543) | M.D. Anderson Cancer Center | 2002-05-01 |
| Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions (NCT00653315) | Par Pharmaceutical, Inc. | 2002-05-01 |
| Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery (NCT00448643) | University of Miami | 2002-05-01 |
| A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy (NCT00074854) | Pfizer | 2002-05-01 |
| Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers (NCT02245438) | Boehringer Ingelheim | 2002-05-01 |
| Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant (NCT00063648) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2002-05-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects (NCT02254096) | Boehringer Ingelheim | 2002-05-01 |
| Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML) (NCT00064584) | Millennium Pharmaceuticals, Inc. | 2002-05-01 |
| Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme (NCT00006452) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-04-10 |
| Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas (NCT00031083) | Biogen | 2002-04-02 |
| Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies (NCT01355822) | University of Jena | 2002-04-01 |
| VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome (NCT00049686) | Vion Pharmaceuticals | 2002-04-01 |
| Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer (NCT00039455) | National Cancer Institute (NCI) | 2002-04-01 |
| CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy (NCT00031941) | National Institutes of Health Clinical Center (CC) | 2002-04-01 |
| Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers (NCT02171442) | Boehringer Ingelheim | 2002-04-01 |
| Treatment for Depressed Preadolescent Girls (NCT00061698) | University of Texas at Austin | 2002-04-01 |
| Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition (NCT01133444) | Dr. Reddy's Laboratories Limited | 2002-04-01 |
| Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients (NCT02269189) | Boehringer Ingelheim | 2002-04-01 |
| Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions (NCT01066767) | Dr. Reddy's Laboratories Limited | 2002-04-01 |
| Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (NCT00093483) | Roswell Park Cancer Institute | 2002-04-01 |
| Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain (NCT00032097) | National Cancer Institute (NCI) | 2002-04-01 |
| Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses (NCT00513643) | Profil Institut für Stoffwechselforschung GmbH | 2002-04-01 |
| VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma (NCT00045266) | Regeneron Pharmaceuticals | 2002-04-01 |
| Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome (NCT00035867) | Telik | 2002-04-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00045448) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer (NCT00039403) | National Cancer Institute (NCI) | 2002-04-01 |
| Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer (NCT00045370) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Oxygen Toxicity of HBOT in Chronic Brain Injury (NCT00592891) | Paul G. Harch, M.D. | 2002-04-01 |
| Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT00039390) | National Cancer Institute (NCI) | 2002-04-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BIIB 722 CL and HPβCD in Young Healthy Male Volunteers (NCT02224079) | Boehringer Ingelheim | 2002-04-01 |
| Testosterone Treatment for Multiple Sclerosis (NCT00405353) | University of California, Los Angeles | 2002-04-01 |
| Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women (NCT00830414) | Teva Pharmaceuticals USA | 2002-04-01 |
| HIV Prevention for Youth With Severe Mental Illness (NCT00496691) | Rhode Island Hospital | 2002-04-01 |
| Pyroxamide in Treating Patients With Advanced Cancer (NCT00042900) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Skin Denervation in Systemic Lupus Erythematosus (NCT00155532) | National Taiwan University Hospital | 2002-04-01 |
| Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis (NCT00043342) | InterMune | 2002-04-01 |
| Leflunomide 20 mg Tablets, Non-Fasting (NCT00834405) | Teva Pharmaceuticals USA | 2002-04-01 |
| Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00039117) | National Cancer Institute (NCI) | 2002-04-01 |
| Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition (NCT01133457) | Dr. Reddy's Laboratories Limited | 2002-04-01 |
| Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions (NCT01066754) | Dr. Reddy's Laboratories Limited | 2002-04-01 |
| Effect of Cabergoline on Weight and Glucose Tolerance (NCT01395602) | Columbia University | 2002-04-01 |
| Ketoconazole Plus Docetaxel to Treat Prostate Cancer (NCT00032825) | National Cancer Institute (NCI) | 2002-03-19 |
| Preventing Learning Problems in Young Children: A Public Health and Physician-Based Outreach (NCT00110292) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-03-01 |
| Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg) (NCT00959439) | Sandoz | 2002-03-01 |
| Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma (NCT01278940) | Oslo University Hospital | 2002-03-01 |
| Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children (NCT00032669) | National Cancer Institute (NCI) | 2002-03-01 |
| Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers (NCT00357292) | Laboratoires Thea | 2002-03-01 |
| Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia (NCT00041379) | LifeTime Pharmaceuticals | 2002-03-01 |
| Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects (NCT02211144) | Boehringer Ingelheim | 2002-03-01 |
| Percutaneous Removal and Margin Ablation for Breast Cancer (NCT00574301) | University of Arkansas | 2002-03-01 |
| Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00033410) | California Cancer Consortium | 2002-03-01 |
| A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions (NCT00865839) | Actavis Inc. | 2002-03-01 |
| This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor (NCT00033202) | Sigma-Tau Research, Inc. | 2002-03-01 |
| Pentoxifylline in Duchenne Muscular Dystrophy (NCT00102453) | Cooperative International Neuromuscular Research Group | 2002-03-01 |
| Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions (NCT00835276) | Teva Pharmaceuticals USA | 2002-03-01 |
| Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer (NCT00053118) | Roswell Park Cancer Institute | 2002-03-01 |
| Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia (NCT00036257) | Astellas Pharma Inc | 2002-03-01 |
| Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease (NCT00032292) | Facet Biotech | 2002-03-01 |
| Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer (NCT00036933) | Memorial Sloan Kettering Cancer Center | 2002-03-01 |
| Pilot Study of Mycophenolate Mofetil in Congenital Uropathies (NCT00193635) | Northwell Health | 2002-03-01 |